An experimental nasal spray has helped clear toxic protein buildups in the brains of mouse models of Alzheimer's. Its ...

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

I am midway through my conversation with Paul Siegel when it hits him: he needs to feed his spider. The tarantula in question ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Shares of Aclaris Therapeutics ACRS rallied 53.2% on Monday and gained another 8.9% during the after-market hours following ...

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

Boston Scientific Corporation BSX recently announced favorable three-year primary endpoint data from the OPTION global ...

Mindray, one of the world's leading developers and providers of advanced medical imaging devices and solutions, launched ...

The $1.2 billion company has some of the biggest podcast bros and athletes touting its praises. Is the greens powder the ...

Researchers at Northwestern Medicine Canning Thoracic Institute have uncovered a startling connection between COVID-19 infections and cancer regression, raising the possibility of using the virus's ...

University at Buffalo neuroscientists have identified the binding site of low-dose ketamine, providing critical insight into how the medication, often described as a wonder drug, alleviates symptoms ...

Persica Pharmaceuticals’ research published in Journal of Orthopaedic Research Spine ahead of anticipated clinical data in 2025 Persica is ... designed for intradiscal injection under image guidance ...